$60.2 B

CELG Mkt cap, 20-Jul-2018

$3.5 B

Celgene Corporation Revenue Q1, 2018
Celgene Corporation Gross profit (Q1, 2018)3.4 B
Celgene Corporation Gross profit margin (Q1, 2018), %96.2%
Celgene Corporation Net income (Q1, 2018)846 M
Celgene Corporation EBIT (Q1, 2018)218 M
Celgene Corporation Cash, 31-Mar-20182.8 B

Celgene Corporation Revenue

Celgene Corporation revenue was $13 b in FY, 2017

Embed Graph

Celgene Corporation Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

6.5 b7.7 b9.3 b11.2 b13 b

Revenue growth, %

18%21%21%

Cost of goods sold

340.4 m385.9 m420.1 m438 m461 m

Gross profit

6.2 b7.3 b8.8 b10.8 b12.5 b

Gross profit Margin, %

95%95%95%96%96%

R&D expense

5.9 b

General and administrative expense

2.9 b

Operating expense total

8.3 b

EBIT

1.8 b2.5 b2.3 b3.2 b4.7 b

EBIT margin, %

28%33%24%28%36%

Interest expense

91.6 m176.1 m310.6 m500.1 m

Pre tax profit

1.7 b2.3 b2 b2.4 b4.3 b

Income tax expense

215.5 m327.5 m421.5 m373.3 m1.4 b

Net Income

1.4 b2 b1.6 b2 b2.9 b

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

2.3 b2.3 b2.5 b2.8 b3 b3 b3.3 b3.3 b3.5 b

Cost of goods sold

100.8 m109.9 m105.9 m110.9 m107.7 m113 m111 m118 m135 m

Gross profit

2.2 b2.2 b2.4 b2.6 b2.9 b2.8 b3.2 b3.2 b3.4 b

Gross profit Margin, %

96%95%96%96%96%96%97%96%96%

R&D expense

1.1 b1.3 b733.2 m948.7 m1.7 b995 m835 m1.3 b2.2 b

General and administrative expense

616.8 m550.3 m543 m732.1 m698 m620 m939 m608 m864 m

Operating expense total

1.9 b2.3 b1.5 b1.9 b2.6 b1.8 b2 b2.2 b3.3 b

EBIT

415.8 m79.6 m1 b823.7 m411.5 m1.1 b1.3 b1.1 b218 m

EBIT margin, %

18%3%40%30%14%38%40%33%6%

Interest expense

48.3 m88.5 m121.9 m123.3 m127.8 m127 m126 m127 m166 m

Pre tax profit

470.8 m(19.9 m)921.6 m695.1 m256.8 m1 b1.1 b991 m1 b

Income tax expense

114.6 m14.2 m120.9 m96.9 m85.4 m84 m69 m3 m184 m

Net Income

372.5 m279.7 m597.8 m508.5 m718.9 m356.2 m(34.1 m)800.7 m598.2 m171.4 m941 m1.1 b988 m846 m

Celgene Corporation Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

3.2 b4.1 b4.9 b6.2 b7 b

Inventories

340.4 m393.1 m443.4 m497.9 m541 m

Current Assets

7.6 b9.7 b9.4 b10.9 b14.9 b

PP&E

593.4 m642.6 m814.1 m929.8 m1.1 b

Goodwill

2 b2.2 b4.9 b4.9 b4.9 b

Total Assets

13.4 b17.3 b27.1 b28.1 b30.1 b

Accounts Payable

156.2 m198.2 m240.8 m247.1 m305 m

Short-term debt

544.8 m605.9 m500.7 m

Current Liabilities

1.9 b2.1 b2 b3 b3 b

Long-term debt

Total Debt

544.8 m605.9 m500.7 m

Total Liabilities

23.2 b

Additional Paid-in Capital

8.7 b9.8 b11.1 b12.4 b13.8 b

Retained Earnings

4.5 b6.5 b8.1 b10.1 b13.1 b

Total Equity

5.6 b6.5 b5.9 b6.6 b6.9 b

Debt to Equity Ratio

0.1 x0.1 x0.1 x

Debt to Assets Ratio

0 x0 x0 x

Financial Leverage

2.4 x2.7 x4.6 x4.3 x4.4 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

2.4 b2.4 b3.2 b3.7 b4.4 b4.5 b6 b4.4 b5.1 b5.5 b5.3 b6.7 b5.5 b2.8 b

Inventories

313.3 m347.8 m360 m372 m386.7 m414.3 m420.9 m470.6 m490.4 m507.9 m509 m533 m537 m536 m

Current Assets

7.6 b6.9 b8.1 b8.8 b9.7 b9.9 b10.2 b8.4 b9.2 b9.6 b11.6 b13.1 b14.8 b7.9 b

PP&E

592.3 m595.7 m605.1 m623.6 m649.7 m675.2 m702 m840 m854 m891.3 m958 m989 m1 b1.3 b

Goodwill

2 b2 b2.2 b2.2 b2.2 b2.2 b4.7 b4.9 b4.9 b4.9 b4.9 b4.9 b4.9 b8 b

Total Assets

13.6 b12.7 b15.6 b16.4 b17.5 b17.7 b27.4 b26 b26.6 b26.8 b28.8 b30.3 b31.7 b34.6 b

Accounts Payable

139.6 m149.4 m184.5 m196.7 m204 m204.9 m189.4 m219.7 m229.8 m235.4 m240 m272 m263 m320 m

Short-term debt

405.9 m869.8 m192.3 m100 m504.4 m1.4 b1.2 b501 m500 m500 m1.4 b

Current Liabilities

1.9 b2.4 b1.5 b1.4 b2.1 b3 b3.1 b1.8 b2 b2.6 b2.6 b3.2 b4 b3.1 b

Total Debt

405.9 m869.8 m192.3 m100 m504.4 m1.4 b1.2 b501 m500 m500 m1.4 b

Total Liabilities

7.7 b8.2 b10.8 b10.6 b10.7 b11.4 b22 b20.9 b21 b21.1 b21.2 b21.9 b21.9 b29.4 b

Additional Paid-in Capital

8.5 b8.9 b9.2 b9.4 b10.2 b10.5 b10.8 b11.4 b11.7 b12 b12.7 b13.2 b13.6 b14.1 b

Retained Earnings

4.3 b4.8 b5.4 b5.9 b7.2 b7.5 b7.5 b8.9 b9.5 b9.6 b11 b12.1 b13.1 b14.4 b

Total Equity

6.3 b5.4 b5.1 b5.5 b5.7 b7.6 b8.4 b9.9 b5.2 b

Financial Leverage

2.8 x5.1 x5.1 x4.8 x4.7 x3.8 x3.6 x3.2 x6.7 x

Celgene Corporation Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

1.4 b2 b1.6 b2 b2.9 b

Depreciation and Amortization

134 m

Accounts Receivable

(101.4 m)(166.3 m)(304.7 m)(222.4 m)(236 m)

Inventories

(89.7 m)(56.5 m)(50.6 m)(55.3 m)(42 m)

Cash From Operating Activities

2.2 b2.8 b2.5 b4 b5.2 b

Cash From Investing Activities

(528.6 m)(1.4 b)(6.3 b)(1 b)(2.9 b)

Long-term Borrowings

(513.9 m)(1.9 b)

Cash From Financing Activities

(553.7 m)(417.4 m)4.6 b(1.6 b)(1.6 b)

Interest Paid

90.8 m196.2 m243.3 m527.2 m539 m

Income Taxes Paid

291.9 m294.6 m361.1 m373 m475 m

Free Cash Flow

2.3 b3 b2.8 b4.2 b5 b

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

1.2 b279.7 m877.5 m1.4 b718.9 m1.1 b1 b800.7 m1.4 b1.6 b941 m2 b3 b846 m

Depreciation and Amortization

71.8 m25.5 m52.1 m78.1 m28.1 m57.8 m86.6 m29.2 m58.5 m89.6 m32 m66 m100 m126 m

Accounts Receivable

(138.7 m)(9.8 m)(61.8 m)(46 m)(59.5 m)(140.9 m)(145.8 m)23.1 m(80.7 m)(143.8 m)17 m(75 m)(139 m)(47 m)

Inventories

(62.6 m)(7 m)(19.1 m)(33.6 m)7.3 m(19.2 m)(27.1 m)(25.6 m)(45.2 m)(62.3 m)(10 m)(32 m)(37 m)6 m

Cash From Operating Activities

1.7 b557.1 m1.1 b2 b856.5 m1.1 b1.4 b974.9 m1.9 b2.6 b853 m2.5 b3.6 b(325 m)

Cash From Investing Activities

(1.4 b)(220.1 m)(1.2 b)(1.4 b)338 m239.7 m(5.9 b)(110.2 m)(185.6 m)(298 m)(1.7 b)(1.6 b)(4 b)(5.7 b)

Cash From Financing Activities

103.7 m(1.2 b)110 m(65.9 m)(908.1 m)(951.3 m)6.4 b(1.3 b)(1.5 b)(1.7 b)1.8 b

Interest Paid

67.4 m52.2 m75.9 m126.2 m50.2 m120.2 m171.1 m200.9 m264.8 m463.3 m198 m262 m461 m190 m

Income Taxes Paid

226.2 m96.6 m193.4 m275 m106.7 m247.2 m345.6 m102.1 m227.1 m345.1 m128 m333 m450 m387 m

Free Cash Flow

1.6 b532.4 m1 b1.9 b814.2 m1 b1.3 b915.3 m1.8 b2.5 b791 m2.3 b3.4 b(413 m)

Celgene Corporation Ratios

USDY, 2018

Financial Leverage

6.7 x
Report incorrect company information

Celgene Corporation Operating Metrics

FY, 2016

Active Clinical Studies

52
Report incorrect company information